Celmatix
Celmatix is a preclinical-stage biotech company dedicated to improving women's health by focusing on ovarian health, leveraging the world's largest structured dataset on ovarian health and outcomes.
Company Overview
Celmatix is a preclinical-stage biotech company dedicated to improving women's lives through enhanced ovarian health. The company leverages extensive datasets and partnerships with industry leaders to discover and develop new therapeutics aimed at women's health issues. Their focus includes the use of proprietary data and research tools to drive innovation in reproductive health.
Proprietary Data and Research Tools
Celmatix has amassed the largest structured dataset on ovarian health and outcomes globally. Their proprietary data includes cohorts with over half a million individuals' treatment histories, genomic data, and biological samples. They utilize an advanced annotation platform that covers all published research in the field, updated with neural network models for better clinical validity and reproductive phenotype classification.
Collaborations and Partnerships
Celmatix partners with leading organizations to advance women's health research. They collaborate with Evotec to identify and validate targets for conditions such as endometriosis, polycystic ovary syndrome (PCOS), and ovarian senescence. With Bayer, Celmatix works on novel PCOS targets and supports the development of new treatments for this condition. The Bill & Melinda Gates Foundation provides funding for their contraceptive discovery and development initiatives.
Initiatives and Programs
Celmatix engages in the Personalized Reproductive Medicine initiative, collaborating with fifteen leading reproductive health centers in the United States. Through these cohort studies, the company aims to advance personalized medicine and improve treatment outcomes in reproductive health. Their discovery programs are geared towards utilizing large-scale datasets to identify new therapeutic targets and develop better treatments for women's reproductive health issues.